Siga Technologies (SIGA) Other Non-Current Assets (2010 - 2025)
Siga Technologies' (SIGA) quarterly Other Non-Current Assets came in at $192893.0 in Q4 2025, down 19.86% YoY from $240683.0 in Q4 2024, and down 4.52% on a QoQ basis from $202015.0 in Q3 2025.
Siga Technologies (SIGA) Other Non-Current Assets (2010 - 2025) Analysis & Trends
Siga Technologies (SIGA) has 16 years of Other Non-Current Assets data on file, last reported at $192893.0 in Q4 2025.
- Quarterly Other Non-Current Assets fell 19.86% year-over-year to $192893.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $192893.0 (down 19.86% YoY) and the FY2025 annual result came in at $192893.0, down 19.86% from the prior year.
- Other Non-Current Assets fell to $192893.0 in Q4 2025, from $202015.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $2.2 million in Q2 2024 to a low of $192893.0 in Q4 2025.
- A 5-year average of $822755.4 and a median of $276009.0 in 2021 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2021 — Other Non-Current Assets slumped 97.43% — and 2023, when it soared 749.77%.
- Tracing SIGA's Other Non-Current Assets over 5 years: stood at $286585.0 in 2021, then declined by 11.88% to $252546.0 in 2022, then surged by 725.01% to $2.1 million in 2023, then tumbled by 88.45% to $240683.0 in 2024, then dropped by 19.86% to $192893.0 in 2025.
- The last three Other Non-Current Assets figures came in at $192893.0 (Q4 2025), $202015.0 (Q3 2025), and $212696.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 56.35 Mn |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 1.79 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 384.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 503.80 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 239.50 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.06 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 59.30 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 304.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 13.00 Mn |
| 10 | Siga Technologies | 214.01 Mn | 59.04 Mn | - | 192,893.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 192,893.00 |
| Sep 30, 2025 | 202,015.00 |
| Jun 30, 2025 | 212,696.00 |
| Mar 31, 2025 | 226,485.00 |
| Dec 31, 2024 | 240,683.00 |
| Sep 30, 2024 | 253,605.00 |
| Jun 30, 2024 | 2.16 Mn |
| Mar 31, 2024 | 2.15 Mn |
| Dec 31, 2023 | 2.08 Mn |
| Sep 30, 2023 | 2.14 Mn |
| Jun 30, 2023 | 2.12 Mn |
| Mar 31, 2023 | 2.04 Mn |
| Dec 31, 2022 | 252,546.00 |
| Sep 30, 2022 | 261,814.00 |
| Jun 30, 2022 | 249,170.00 |
| Mar 31, 2022 | 265,433.00 |
| Dec 31, 2021 | 286,585.00 |
| Sep 30, 2021 | 306,722.00 |
| Jun 30, 2021 | 392,665.00 |
| Mar 31, 2021 | 419,448.00 |